3-(2-methylpyrazolo[1,5-a]pyrimidin-6-yl)propan-1-amine hydrochloride, 95.0%, 250mg

tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 1g

1-Acetyl-4-piperidone, 98.0%, 10g

2,2'-((6-Chloro-2,4-dioxopyrimidine-1,3(2H,4H)-diyl)bis(methylene))dibenzonitrile, 98%, 10mg

(5-Bromobenzofuran-2-yl)boronic acid, 95.0%, 1g

Methyl 3-thiophenecarboxylate, 95.0%, 25g

5-Aminooxindole, 95.0%, 1g

Butylhydroxytoluène, min 99,7 %, pour la synthèse, 250 g, emballage plastique.

4-Aminobenzonitrile, 98.0%, 100g

Pièce de transition, 14/23, 24/29, 1 pièce

4-[(tert-Butyldimethylsilyl)oxy]benzaldehyde, 96%, 1g

trans-2-Octenal>96.0%(GC)10mL

2-(4-(Difluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g